zoledronic acid has been researched along with Necrosis in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Qu, X; Shan, L; Wang, Y; Wang, Z; Wu, K | 1 |
| Ohta, K; Yoshimura, H | 1 |
| Jani, C; Page, S; Sehra, S; Ueberroth, J | 1 |
| Leung, YY; Rao, NJ; Wang, JY; Yu, RQ; Zheng, LW | 1 |
| Bahleda, R; Escudier, B; Gueutin, V; Izzedine, H; Rouvier, P; Soria, JC; Varga, A | 1 |
| Endo, Y; Kiyama, T; Kuroishi, T; Oizumi, T; Okada, S; Sasaki, K; Sato, E; Sugawara, S; Takahashi, T; Tanaka, Y | 1 |
| Alici, O; Bereket, C; Desteli, EE; Erdogan, M; Ilkaya, F; Ozkan, N; Sener, I | 1 |
| Aki, SZ; Cetiner, M; Cetiner, S; Gultekin, SE; Haznedar, R; Kahraman, SA; Kocakahyaoglu, B; Sucak, GT | 1 |
| Akens, MK; Burch, S; Whyne, CM; Wilson, BC; Wise-Milestone, L; Won, E; Yee, AJ | 1 |
| Endo, Y; Funayama, H; Kawamura, H; Kumamoto, H; Kuroishi, T; Oizumi, T; Sasaki, K; Sugawara, S; Takahashi, H; Yamaguchi, K; Yamamoto, M; Yokoyama, M | 1 |
| Allen, MR; Burr, DB; Kubek, DJ | 1 |
| Endo, K; Hanaoka, N; Nishisho, T; Takahashi, M; Yasui, N | 1 |
| Tanvetyanon, T | 1 |
| Blanchard, F; Charrier, C; Coipeau, P; Couillaud, S; Gouin, F; Heymann, D; Heymann, MF; Ory, B; Redini, F; Thiery, JP | 1 |
| Alati, C; Allegra, A; Alonci, A; Cicciù, M; De Ponte, FS; Musolino, C; Nastro, E; Oteri, G; Quartarone, E | 1 |
| Bellomi, M; Bruschini, R; Cossu Rocca, M; Goldhirsch, A; Nole, F; Preda, L; Sanna, G; Verri, E | 1 |
| Andriani, A; Barbarano, L; Bibas, M; Cafro, AM; D'Avanzo, G; Gaglioti, D; Morra, E; Nichelatti, M; Nosari, AM; Riva, F; Taroni, A | 1 |
17 other study(ies) available for zoledronic acid and Necrosis
| Article | Year |
|---|---|
Zoledronate inhibits the differentiation potential of adipose-derived stem cells into osteoblasts in repairing jaw necrosis.
Topics: Animals; Cathepsin K; Cell Movement; Cell Proliferation; Cells, Cultured; Coculture Techniques; Jaw; Mesenchymal Stem Cells; Necrosis; Osteoblasts; Osteogenesis; Rats; Receptor, Fibroblast Growth Factor, Type 3; Zoledronic Acid | 2020 |
Medication-Related Osteonecrosis of the Jaw.
Topics: Aged; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Humans; Male; Maxilla; Necrosis; Prostatic Neoplasms; Tomography, X-Ray Computed; Zoledronic Acid | 2020 |
Acute Tubular Necrosis Caused by Zoledronic Acid Infusion in a Patient With Osteoporosis.
Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Infusions, Intravenous; Necrosis; Osteoporosis; Zoledronic Acid | 2021 |
Role of Periapical Diseases in Medication-Related Osteonecrosis of the Jaws.
Topics: Alveolar Bone Loss; Animals; Bone Density; Bone Density Conservation Agents; Diphosphonates; Disease Models, Animal; Humans; Imidazoles; Jaw; Mandible; Mice; Molar; Necrosis; Osteocytes; Osteonecrosis; Periapical Diseases; Tomography, X-Ray Computed; Zoledronic Acid | 2017 |
Acute tubular necrosis associated with mTOR inhibitor therapy: a real entity biopsy-proven.
Topics: Acute Kidney Injury; Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Carcinoma, Renal Cell; Cisplatin; Cyclophosphamide; Diphosphonates; Doxorubicin; Female; Glutamates; Guanine; Humans; Imidazoles; Indoles; Interferons; Kidney Tubules; Lung Neoplasms; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Necrosis; Nephrectomy; Pemetrexed; Prednisone; Pyrroles; Sunitinib; TOR Serine-Threonine Kinases; Vincristine; Zoledronic Acid | 2013 |
Inhibition of phosphate transporters ameliorates the inflammatory and necrotic side effects of the nitrogen-containing bisphosphonate zoledronate in mice.
Topics: Animals; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Foscarnet; Imidazoles; Mice; Mice, Inbred BALB C; Molecular Structure; Necrosis; Osteitis; Phosphate Transport Proteins; Zoledronic Acid | 2013 |
The effect of zoledronic acid on growth plates and high turnover bones.
Topics: Animals; Bone Density Conservation Agents; Bone Remodeling; Diphosphonates; Female; Gingiva; Growth Plate; Imidazoles; Mandible; Necrosis; Rats; Rats, Sprague-Dawley; Tibia; Zoledronic Acid | 2014 |
Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid.
Topics: Adult; Aged; Bone Density Conservation Agents; Bone Resorption; Dexamethasone; Diphosphonates; Female; Humans; Imidazoles; Jaw; Male; Middle Aged; Multiple Myeloma; Necrosis; Osteoclasts; Osteonecrosis; Thalidomide; Zoledronic Acid | 2009 |
Beyond bisphosphonates: photodynamic therapy structurally augments metastatically involved vertebrae and destroys tumor tissue.
Topics: Animals; Bone Development; Breast Neoplasms; Cell Line, Tumor; Diphosphonates; Female; Humans; Imidazoles; Necrosis; Photochemotherapy; Photosensitizing Agents; Porphyrins; Rats; Rats, Nude; Spinal Neoplasms; Spine; Time Factors; Verteporfin; X-Ray Microtomography; Xenograft Model Antitumor Assays; Zoledronic Acid | 2010 |
Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Ear, External; Etidronic Acid; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Inflammation Mediators; Injections, Intraperitoneal; Injections, Subcutaneous; Interleukin-1; Male; Mice; Mice, Inbred BALB C; Necrosis; Osteonecrosis; Osteosclerosis; Pamidronate; Pravastatin; Radionuclide Imaging; Radiopharmaceuticals; Risedronic Acid; Technetium; Tibia; Time Factors; Zoledronic Acid | 2010 |
Ovariectomy stimulates and bisphosphonates inhibit intracortical remodeling in the mouse mandible.
Topics: Alveolar Process; Animals; Bone Density Conservation Agents; Bone Matrix; Bone Remodeling; Calcification, Physiologic; Coloring Agents; Dentin; Diphosphonates; Female; Femur; Fluoresceins; Fluorescent Dyes; Haversian System; Imidazoles; Mandible; Mice; Mice, Inbred C3H; Necrosis; Osteogenesis; Ovariectomy; Periodontal Ligament; Pharmaceutical Vehicles; Rosaniline Dyes; Tooth Calcification; Zoledronic Acid | 2010 |
Locally administered zoledronic Acid therapy for giant cell tumor of bone.
Topics: Adult; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Bone Substitutes; Bone Transplantation; Curettage; Diphosphonates; Giant Cell Tumor of Bone; Humans; Hydroxyapatites; Imidazoles; Knee Joint; Male; Necrosis; Osteoclasts; Osteolysis; Prostheses and Implants; Radiography; Range of Motion, Articular; Remission Induction; Tibia; Zoledronic Acid | 2011 |
Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.
Topics: Analgesics; Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Fractures, Bone; Humans; Imidazoles; Jaw; Male; Necrosis; Osteomyelitis; Osteopetrosis; Pain; Pain Measurement; Pamidronate; Prostatic Neoplasms; Quality of Life; Research Design; Surveys and Questionnaires; Time Factors; Treatment Outcome; Zoledronic Acid | 2005 |
Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Remodeling; Caspases; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Fibrosis; Ifosfamide; Imidazoles; Male; Necrosis; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteoblasts; Osteogenesis; Osteosarcoma; Rats; Rats, Sprague-Dawley; S Phase; Survival Rate; Tibia; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid | 2005 |
Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer.
Topics: Alendronate; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Mandible; Maxilla; Middle Aged; Multiple Myeloma; Necrosis; Osteonecrosis; Pamidronate; Tomography, X-Ray Computed; Zoledronic Acid | 2007 |
The role of surgery in jaw bone necrosis associated with long-term use of bisphosphonates.
Topics: Adenocarcinoma; Bone Neoplasms; Bone Plates; Bone Screws; Breast Neoplasms; Cutaneous Fistula; Diphosphonates; Female; Humans; Imidazoles; Male; Mandible; Mandibular Diseases; Middle Aged; Necrosis; Oral Fistula; Osteolysis; Osteomyelitis; Pamidronate; Prostatic Neoplasms; Recurrence; Tomography, X-Ray Computed; Zoledronic Acid | 2008 |
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: definition and management of the risk related to zoledronic acid.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Diseases; Clodronic Acid; Diphosphonates; Female; Humans; Imidazoles; Male; Mandible; Maxilla; Middle Aged; Multiple Myeloma; Necrosis; Zoledronic Acid | 2008 |